特鋭德(300001.SZ):特來電引進戰略投資者 已收到約2.85億元增資款
格隆匯6月29日丨特鋭德(300001.SZ)公佈,此前披露,公司於2021年6月18日召開的第四屆董事會第二十六次會議審議通過《關於特來電增資擴股暨引進戰略投資者的議案》,同意子公司特來電新能源股份有限公司(“特來電”)通過增資擴股方式引進戰略投資者,此次增資總金額約3億元,增發股份的價格為人民幣14.60元/股,投後估值約為136億元。普洛斯、國家電投、三峽集團等國內外知名、強資源的戰略投資者通過其旗下基金入股特來電。
截止目前,特來電已收到284,846,000元人民幣的增資款,並完成相關工商登記變更手續,取得了由青島市市場監督管理局換髮的《營業執照》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.